Skip to content

Maze Therapeutics vs QurAlis

Maze Therapeutics logo

Maze Therapeutics

At Maze, we envision a world where genetic insights inspire new medicines

156 employees · est. 2018 · South San Francisco, United...

VS
QurAlis logo

QurAlis

Neuro Pioneers on a Quest to Cure

89 employees · est. 2016 · Cambridge, United States

QurAlis is the older company (2018 vs 2016).

Side-by-Side Comparison

Maze Therapeutics QurAlis
Founded
2018 2016 older
Headquarters
South San Francisco, United States Cambridge, United States
Employees
156 89
Industry
Biotechnology, Health and Wellness Biotechnology, Health Care, Health and Wellness
Funding Stage
Series D Not tracked yet
Total Funding
$496.00M $160.42M
Funding Rounds
4 5
Services
Not tracked yet Development of Precision Medicines, Research in Neurodegenerative Diseases, Advancement of Therapeutic Candidates, Proprietary Anti-Sense Oligonucleotide Platform
Target Customers
Not tracked yet Patients with ALS, Patients with Neurodegenerative Diseases, Healthcare Providers, Neurology Researchers
Taxonomy
Genetic InsightsLifesaving MedicinesHuman GeneticsFunctional GenomicsGenetic ModifiersSevere Diseases +8 Neuro PioneersPrecision MedicineNeurodegenerative DiseasesALSFTDInnovation +6
Website
mazetx.com quralis.com
Maze Therapeutics logo

About Maze Therapeutics

Maze Therapeutics is a biotechnology startup that envisions a world where genetic insights inspire new medicines. Founded in 2018 and headquartered in the United States, they are focused on translating novel genetic insights into lifesaving medicines. Their approach integrates human genetics and fun...

QurAlis logo

About QurAlis

QurAlis, founded in 2016, is a biotechnology startup located in the United States, specializing in precision medicines for neurodegenerative diseases. Their slogan, "Neuro Pioneers on a Quest to Cure," encapsulates their mission to transform the treatment landscape for diseases like amyotrophic late...

Also comparing in this category

Comparing more than these two?

Get Maze Therapeutics, QurAlis and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Maze Therapeutics compare?

A PDF of Maze Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Maze Therapeutics was founded in 2018, based in South San Francisco, United States, with 156 employees. Maze Therapeutics is a biotechnology startup that envisions a world where genetic insights inspire new medicines. Founded in 2018 and headquartered in the United States, they are focused on translatin. QurAlis was founded in 2016, based in Cambridge, United States, with 89 employees. QurAlis, founded in 2016, is a biotechnology startup located in the United States, specializing in precision medicines for neurodegenerative diseases. Their slogan, "Neuro Pioneers on a Quest to Cure,.
Maze Therapeutics has raised $496.00M and QurAlis $160.42M. Latest stage: Maze Therapeutics Series D.
Both work in Biotechnology and Health and Wellness.

Compare Maze Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Maze Therapeutics on 9 Jun 2026, and QurAlis on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout